http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0761228-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97ddd4d1d0ebc8a7d2c8e7d214d08cf3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e90f4591352d28b6455891f2fd7609 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdf06c6f4813a04af3b9f076ca087966 |
| publicationDate | 2002-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0761228-B1 |
| titleOfInvention | Composition containing gamma interferon for treatment of prurigo |
| abstract | As a remedy for prurigo, IFN- gamma is administered systemically, preferably intravenously and still preferably via drip infusion, in a daily dose of from 250,000 JRU to 4,000,000 JRU preferably once a day or in several portions depending on the conditions of the patient and side effects. The administration method and dose can be changed depending on the conditions, age, etc., of the patient. IFN- gamma is highly effective in the treatment of prurigo. The action of IFN- gamma to normalize the imbalance in peripheral lymphocytes is suggested as the mechanism for the efficacy of IFN- gamma in the treatment of prurigo. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8490578-B2 |
| priorityDate | 1995-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.